Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-04-20
1983-07-05
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424341, 568640, 568641, 568631, A01N 3114, C07C 43205
Patent
active
043918280
ABSTRACT:
Novel dibutylorthobenzylmethoxybenzenes having the structure ##STR1## wherein R is hydrogen, lower alkyl or lower alkoxy and novel dibutylorthocinnamylmethoxybenzenes are disclosed as growth inhibitors for mosquito larvae.
REFERENCES:
patent: 3839586 (1974-10-01), Ludvik
patent: 3920846 (1975-11-01), Hanauye et al.
patent: 3973040 (1976-08-01), Jurd
patent: 4357344 (1982-11-01), Jurd
Mosquito News, vol. 31, No. 4, pp. 513-516, (1971).
Chemical Abstracts, vol. 80, No. 768h, (1974).
Connor Margaret A.
Helfin Bernard
McConnell David G.
Silverstein M. Howard
The United States of America as represented by the Secretary of
LandOfFree
Dibutylorthobenzylmethoxybenzenes and dibutylorthocinnamylmethox does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dibutylorthobenzylmethoxybenzenes and dibutylorthocinnamylmethox, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibutylorthobenzylmethoxybenzenes and dibutylorthocinnamylmethox will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439788